
About Mel-Mont Medical
Mel-Mont Medical is a Healthcare company based in Doral (United States) founded in 2014 by Liliana Montes and Frank Melendez. Molecular screening devices for early infectious disease detection are developed. Mel-Mont Medical has raised $10.15 million across 3 funding rounds. Its chief executive, as recorded, is Frank Melendez. Its focus areas include Life Sciences, Infectious Diseases, Medical Devices and Screening. Its competitors include OpGen, Day Zero Diagnostics and Clear Labs; 3 of its 3 listed competitors have raised funding.
Company details
Developer of molecular screening devices for the early detection of infectious diseases. The company develops a diversified portfolio of proprietary technologies and medical devices for the early identification of DNA and RNA virus-related pathologies. The product portfolio includes XytoTest and Anal test for cervical cancer, and HR-HPV DNA detection. Also, offers in-vitro diagnostic tests for the detection of HPV infections.
- Headquarters Doral, United States
- Founders Liliana Montes, Frank Melendez
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mel-montmedical.com
- Social LinkedIn Facebook
- Total Equity Funding$10.15M (USD)
in 3 rounds
- Latest Funding Round$250K (USD), Series A
Dec 2025
Funding Insights of Mel-Mont Medical
Mel-Mont Medical has successfully raised a total of $10.15M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $250 thousand completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.15M
- Total Rounds 3
- Last Round Series A — $250,000
- First Round $3M
(Nov 2020)
All 3 funding rounds of Mel-Mont Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2025 | $250,000 | Series A | – | – | – |
| Aug 2023 | $6.9M | Series A | – | – | – |
| Nov 2020 | $3M | Seed | – | – | – |
People of Mel-Mont Medical
2 people are tracked at Mel-Mont Medical (2 in leadership).
| Name | Role | Group |
|---|---|---|
Liliana Montes | Co-Founder | Leadership |
Frank Melendez | Co-Founder & CEO | Leadership |
Complete people profiles for Mel-Mont Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Mel-Mont Medical
3 dated milestones of Mel-Mont Medical across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Mel-Mont Medical is founded.
- Funding First funding round of $3.0M.
- Funding Latest funding round, Series A, of $250K.
Competitors of Mel-Mont Medical
Mel-Mont Medical has 3 listed competitors in our database, 3 of them funded. They include OpGen, Day Zero Diagnostics and Clear Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| opgen.com | 2002 | Rockville, United States | $77.51M | 100 | Developer of diagnostics and bioinformatics platforms for providers | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. | |
| clearlabs.com | 2014 | Menlo Park, United States | $171.09M | 55 | Food safety technologies are provided for pathogen identification. |
Detailed competitors of Mel-Mont Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Mel-Mont Medical (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mel-Mont Medical
Complete news archive for Mel-Mont Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mel-Mont Medical
Mel-Mont Medical was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Mel-Mont Medical is headquartered in Doral, United States. It is registered at Doral, Florida, United States.
Frank Melendez is the CEO of Mel-Mont Medical, as recorded in our data. They have also founded this company.
Mel-Mont Medical is a funded company, having raised a total of $10.15M across 3 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on Nov 2020.
Developer of molecular screening devices for the early detection of infectious diseases. The company develops a diversified portfolio of proprietary technologies and medical devices for the early identification of DNA and RNA virus-related pathologies. The product portfolio includes XytoTest and Anal test for cervical cancer, and HR-HPV DNA detection. Also, offers in-vitro diagnostic tests for the detection of HPV infections.
Mel-Mont Medical's top competitors include Clear Labs, Day Zero Diagnostics and OpGen.
